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Background: Recent guidelines recommend mitral valve (MV) repair for severe mitral regurgitation (MR) before symptom onset or left ventricular 
(LV) dysfunction. However, it is still controversial whether MV repair for asymptomatic severe MR patient with preserved LV function and without atrial 
fibrillation (AF) or pulmonary hypertension (PH) should be performed even at experienced surgical center.
Methods: A total of 351 patients (age: 55±13 year-old, male/female: 216/135) who underwent MV repair for MR due to MV prolapse with only 
modest symptoms (NYHA≤2) were evaluated. Patients were divided into 2 groups: group B, consisting of 147 patients with at least one of the 
following conditions; left ventricular (LV) ejection fraction (EF) ≤60%, LV end-systolic dimension (Ds) ≥40mm, AF, or PH, and group A, the remaining 
204 patients without any of these conditions. Long-term clinical outcomes were compared between the 2 groups.
Results: The mean follow-up period was 5.8 years. The Kaplan-Meier survival curve showed that group B had higher mortality than group A at 10 
years (A vs B; 96% vs 87%: P=0.013). Valve-related events, including major bleeding, thromboembolism, re-do MV surgery, and admission due to 
heart failure were significantly fewer in group A than in group B at 10 years (A vs B; 92% vs 76%: P=0.005).
Conclusion: Early MV repair before LV dysfunction, PH or AF provides better clinical outcomes. Early repair should be considered for patients with 
degenerative MR at experienced surgical center.
